Short answer
EPAM Systems (EPAM) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). EPAM announced fiscal Q3 2026 results for the quarter ended September 30, 2026.
EPAM Systems 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- EPAM announced fiscal Q3 2026 results for the quarter ended September 30, 2026
- Detailed operating results and management commentary are provided in Exhibit 99.1, including the accompanying infographic
- Investor focus: quarterly performance metrics, outlook, and any changes to operating trends disclosed in the exhibit
Item 8.01 · Other Events
- Board authorized up to $1.8 billion in EPAM common-stock repurchases
- New authorization replaces the previous $1 billion program approved in October 2025
- Program provides substantial capital-return capacity and may support per-share metrics
- Repurchase execution timing and volume remain subject to market conditions and company discretion
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $1.426B, up 2.3% YoY, with organic constant-currency growth of 2.5%, indicating modest demand expansion
- GAAP operating margin 12.3% vs 10.4%, while non-GAAP margin reached 16.7% vs 16.0%, showing meaningful profitability improvement
- GAAP diluted EPS $2.53, up 32.5%, and non-GAAP EPS $3.51, up 14.0%, benefiting from margin expansion and lower diluted shares
- Share repurchase authorization increased to $1.8B, including a planned $500M accelerated repurchase funded by cash and credit borrowings
- 2026 outlook now calls for revenue growth of 3.5% to 3.7% and non-GAAP EPS of $13.23 to $13.31, alongside at least 50% free-cash-flow returns annually from 2027 through 2029
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other EPAM Systems 8-K filings
Get the next EPAM 8-K as it lands
Follow EPAM for push alerts, or ask the research agent what this filing means.